1. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes
   Li-Chiung Lin et al, 2017, Cancer Letters CrossRef
2. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
   Saghar Yousefnia et al, 2018, Gene CrossRef
3. Targeting the endocannabinoid system as a potential anticancer approach
   Rico Schwarz et al, 2018, Drug Metabolism Reviews CrossRef
4. Lipid pathway deregulation in advanced prostate cancer.
   Laura Galbraith et al, 2018, Pharmacol Res CrossRef
5. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
   Shogo Senga et al, 2018, Biochim Biophys Acta Mol Cell Biol Lipids CrossRef
6. Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression
   Dejuan Yang et al, 2018, Cell Commun Signal CrossRef
7. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers
   Mina Amiri et al, 2018, Gene CrossRef
8. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
   Hyung Kyu Park et al, 2015, J Korean Med Sci CrossRef
9. Evaluation of P21 and peroxisome proliferator-activated receptor gamma as prognostic markers for renal cell carcinoma
   Aliaa Atef et al, 2018, Egyptian Journal of Pathology CrossRef
10. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
    K Nitschke et al, 2020, World J Urol CrossRef
11. Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
    Robert Ramer et al, 2019, Front. Pharmacol. CrossRef
12. The Role of Nuclear Receptors in Prostate Cancer
    Masaki Shiota et al, 2019, Cells CrossRef
13. Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical location
    Risa Nakagawa et al, 2019, Med Mol Morphol CrossRef
14. High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells
    Koichiro Kawaguchi et al, 2016, FEBS Open Bio CrossRef
15. Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target.
    Abdulghani A Naeem et al, 2019, Precis Clin Med CrossRef
16. WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer
    Damien A Leach et al, 2016 CrossRef
17. PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity
    Patricia Canto et al, 2017, CBM CrossRef
18. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth
    Gregory Carbonetti et al, 2019, Prostate CrossRef
19. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis
    Gregory Carbonetti et al, 2019, Sci Rep CrossRef
20. A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
    Shogo Senga et al, 2018, Oncotarget CrossRef
21. Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
    Waseem Al-Jameel et al, 2017, Oncotarget CrossRef
22. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter
    Farzad S. Forootan et al, 2016, Oncotarget CrossRef
23. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance
    Majed Saad Al Fayi et al, 2016, Oncotarget CrossRef
24. Heterogeneity of PTEN and PPAR-γ in cancer and their prognostic application to bladder cancer.
    Zhouzhou Zhang et al, 2019, Exp Ther Med CrossRef
25. FABP5 as a novel molecular target in prostate cancer.
    Saoirse Elizabeth O'Sullivan et al, 2020, Drug Discov Today CrossRef
26. The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate cancer cells
    Rong‐Zong Liu et al, 2020, Mol Oncol CrossRef
27. An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis
    Rong-Zong Liu et al, 2020, Cancers CrossRef
28. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance
    Rana Ezzeddini et al, 2021, J Physiol Biochem CrossRef
29. Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers
    Rahul Mallick et al, 2021, Progress in Lipid Research CrossRef
30. Prostate Cancer Progression: as a Matter of Fats
    Natalia Scaglia et al, 2021, Front. Oncol. CrossRef
31. Expressions of Nuclear Factor-kappa B and Peroxisome Proliferator-activated Receptor-Gamma Proportional with Clinical Staging of Nasopharyngeal Carcinoma
    Farhat Farhat et al, 2021, Open Access Maced J Med Sci CrossRef
32. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
    Juan C. Pardo et al, 2022, Nutrients CrossRef
33. Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
    Anita Thomas et al, 2022, Cancers CrossRef
34. The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases.
    Binyue Xu et al, 2022, Front Cell Dev Biol CrossRef
35. Transcriptome-based biomarker gene screening and evaluation of the extracellular fatty acid-binding protein (Ex-FABP) on immune and angiogenesis-related genes in chicken erythrocytes of tibial dyschondroplasia
    Ali Raza Jahejo et al, 2022, BMC Genomics CrossRef
36. Physical exercise regulates apoptosis and prostatic inflammatory effects induced by high-fat diet in PPAR-alpha-deleted mice
    Maria Eduarda Almeida Tavares et al, 2022, Prostaglandins & Other Lipid Mediators CrossRef
37. FABP5 controls macrophage alternative activation and allergic asthma by selectively programming long-chain unsaturated fatty acid metabolism
    Yangxiao Hou et al, 2022, Cell Reports CrossRef
38. Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells
    Jiacheng Zhang et al, 2023, Cell Biology International CrossRef
39. Research Progress of PPARγ in Prostate Cancer
    耀 常, 2023, ACM CrossRef
40. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway
    Zhen Wang et al, 2023, IJMS CrossRef
41. The emerging role of fatty acid binding protein 5 (FABP5) in cancers
    William George Warren et al, 2023, Drug Discovery Today CrossRef
42. FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells
    Abdulghani Naeem et al, 2023, Int J Oncol CrossRef
43. Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use
    Saud A Abdulsamad, 2024, Am J Cancer Res CrossRef
44. Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer
    Brigitte Hantusch et al, 2024, IJMS CrossRef
45. null
    Asim K. Duttaroy, 2024 CrossRef
46. null
    Asim K. Duttaroy, 2024 CrossRef
47. Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression
    Kia T. Liermann-Wooldrik et al, 2024, IJMS CrossRef